Akèy › Skleroz Amiotrofik Lateral › Massachusetts
Etid klinik pou Skleroz Amiotrofik Lateral nan Massachusetts
23 etid pou Skleroz Amiotrofik Lateral ap chèche patisipan nan sit nan Massachusetts.
Vil nan Massachusetts
Tèks ofisyèl etid la (Anglè)
RAPA-501 Therapy for ALS
- Massachusetts General Hospital, Boston
Ap rekriteFaz 2/3
Laj 18 ak plis · Tout sèks · Mizajou Sep 29, 2026 · NCT04220190A Study to Investigate the Safety and Pharmacodynamics of a Single Intrathecal Injection (IT) of INS1202 in Participants With Amyotrophic Lateral Sclerosis (ALS)
- USA009, Worcester
Ap rekriteFaz 1
Laj 18 a 79 · Tout sèks · Mizajou Sep 23, 2026 · NCT07290062Pridopidine Phase 3 Study to Evaluate Efficacy and Safety in ALS
- Sean M. Healey & AMG Center for ALS, Boston
Ap rekriteFaz 3
Laj 18 a 80 · Tout sèks · Mizajou Sep 22, 2026 · NCT07322003RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
- Dana Farber Cancer Institute, Boston
- University of Massachusetts Chan Medical Center, Worcester
Ap rekriteFaz 2
Laj 18 a 80 · Tout sèks · Mizajou Sep 15, 2026 · NCT07002034Study is to Assess the Safety and Tolerability of VTx-002 in Participants With ALS
- Sean M. Healey & AMG Center for ALS at Massachusetts General Hospital, Boston
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Sep 10, 2026 · NCT07287397Controlling Amyotrophic Lateral Sclerosis Motor Neuron Excitability Study
- Beth Israel Deaconess Medical Center, Boston
Ap rekrite
Laj 18 a 80 · Tout sèks · Mizajou Sep 10, 2026 · NCT06649955Usnoflast Neuromuscular Investigation for Treatment Efficacy in Amyotrophic Lateral Sclerosis
- Zydus US010, Boston
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 1, 2026 · NCT07023835ASSESS ALL ALS Study
- Massachusetts General Brigham, Boston
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Aug 24, 2026 · NCT06578195PREVENT ALL ALS Study
- Massachusetts General Brigham, Boston
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Aug 24, 2026 · NCT06581861Study of COYA 302 for the Treatment of ALS
- Massachusetts General Hospital, Boston
Ap rekriteFaz 2/3
Laj 18 a 80 · Tout sèks · Mizajou Aug 6, 2026 · NCT07161999ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration (ALLFTD)
- Massachusetts General Hospital, Boston
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Jul 30, 2026 · NCT04363684Tofersen in Non-SOD1 ALS
- Massachusetts General Hospital, Boston
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Jun 25, 2026 · NCT07294144Feasibility of the BrainGate2 Neural Interface System in Persons With Tetraplegia
- Massachusetts General Hospital, Boston
Ap rekrite
Laj 18 a 80 · Tout sèks · Mizajou Jun 2, 2026 · NCT05724173BrainGate2: Feasibility Study of an Intracortical Neural Interface System for Persons With Tetraplegia
- Massachusetts General Hospital, Boston
Ap rekrite
Laj 18 a 80 · Tout sèks · Mizajou Jun 1, 2026 · NCT00912041ALS/MND Natural History Study Data Repository
- Lahey Clinic, Burlington
Ap rekriteEtid obsèvasyon
Laj 18 a 90 · Tout sèks · Mizajou May 20, 2026 · NCT05966038EIM Via the Myolex mScan as an ALS Biomarker
- Massachusetts General Hospital, Boston
- Beth Israel Deaconess Medical Center, Boston
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Apr 22, 2026 · NCT06491732Connect-One: Early Feasibility Study of Connexus® Brain-Computer Interface (BCI)
- Massachusetts General Hospital, Boston
Ap rekrite
Laj 22 a 75 · Tout sèks · Mizajou Apr 14, 2026 · NCT07357428AMX0114 in Adult Participants With Amyotrophic Lateral Sclerosis
- Massachusetts General Hospital, Healey & AMG Center for ALS, Boston
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Apr 14, 2026 · NCT06665165A Study to Learn More About the Long-Term Safety of Tofersen (Qalsody) in Participants With Superoxide Dismutase 1 (SOD-1) Amyotrophic Lateral Sclerosis (ALS)
- Mass General Hospital -MGH, Boston
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Apr 9, 2026 · NCT07259980Intermuscular Coherence as a Biomarker for ALS
- Massachusetts General Hospital, Boston
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 20 a 90 · Tout sèks · Mizajou Feb 9, 2026 · NCT05104710Target ALS Biomarker Study; Longitudinal Biofluids, Clinical Measures, and At Home Measures
- Massachusetts General Hospital, Boston
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Nov 21, 2025 · NCT05137665Efficacy and Safety of Masitinib Versus Placebo in the Treatment of ALS Patients
- Lahey Hospital and Medical Center, Burlington
Ap rekriteFaz 3
Laj 18 a 81 · Tout sèks · Mizajou Sep 12, 2025 · NCT03127267ALS Research Collaborative
- ALS Therapy Development Institute, Watertown
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Mar 20, 2025 · NCT06885918Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.